within Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01A_AntiinflammatoryAndAntirheumaticProductsNonSteroids.M01AC02_Tenoxicam;
model Tenoxicam_1 
   extends Pharmacolibrary.Drugs.ATC.M.M01AC02_1;

  annotation(Documentation(
    info ="<html><body><p>Tenoxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class. It is primarily used for the treatment of pain and inflammation in musculoskeletal and joint disorders such as rheumatoid arthritis and osteoarthritis. It is approved for clinical use in many countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy volunteers after intravenous administration.</p><h4>References</h4><ol><li><p>Nilsen, OG (1994). Clinical pharmacokinetics of tenoxicam. <i>Clinical pharmacokinetics</i> 26(1) 16–43. DOI:<a href=&quot;https://doi.org/10.2165/00003088-199426010-00003&quot;>10.2165/00003088-199426010-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8137596/&quot;>https://pubmed.ncbi.nlm.nih.gov/8137596</a></p></li><li><p>Heintz, RC, et al., &amp; Jeunet, FS (1984). Pharmacokinetics of tenoxicam in healthy human volunteers. <i>European journal of rheumatology and inflammation</i> 7(2) 33–44. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6336292/&quot;>https://pubmed.ncbi.nlm.nih.gov/6336292</a></p></li><li><p>Lopez-Bustamante, LG, et al., &amp; Fos, D (1993). Tenoxicam: acute dose-dependent disposition studies in rats. <i>Journal of pharmaceutical sciences</i> 82(8) 851–853. DOI:<a href=&quot;https://doi.org/10.1002/jps.2600820820&quot;>10.1002/jps.2600820820</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8377127/&quot;>https://pubmed.ncbi.nlm.nih.gov/8377127</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Tenoxicam_1;
